Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Tables)

v3.22.1
Stockholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of warrant and stock option grants with time-based vesting
    Warrant Grants     Stock Option Grants     Restricted
Stock Units		  
    Number of
shares
subject to
warrants		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
options		    

Weighted-
average
exercise
price per
share

     Number of shares
subject to
restricted
stock units		  
Balance at December 31, 2020     672,459     $ 8.09       118,388     $ 3.25       2,301,053  
Granted     389,344       2.30      
-
      
-
       894,885  
Exercised     (6,579 )     1.96      
-
      
-
       (884,348 )
Cancelled/Expired     (11,699 )    
-
      
-
      
-
       (150,833 )
Balance at December 31, 2021     1,043,525     $ 2.57       118,388     $ 3.25       2,160,757  
Exercisable at December 31, 2021     1,043,525     $ 2.57       118,388     $ 3.25       1,631,924  

 

    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of
shares
subject to
warrants		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
options		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
restricted
stock units		     Weighted-
average
exercise
price per
share		  
Balance at December 31, 2019     1,311,916     $ 9.35       338,595     $ 5.26       630,303     $
          -
  
Granted     146,053       4.51      
-
      
-
       2,222,984      
-
  
Exercised     (681,619 )     5.57       (160,291 )     4.78       (77,234 )    
-
  
Expired     (103,891 )     35.54       (59,916 )     10.55                  
Cancelled/Forfeited    
-
      
-
      
-
      
-
       (475,000 )    
-
  
Balance at December 31, 2020     672,459     $ 8.09       118,388     $ 3.25       2,301,053     $
-
  
Exercisable at December 31, 2020     672,459     $ 8.09       118,388     $ 3.25       2,301,053     $
-
  

 
Schedule of fair value of the warrants as of original issuance date
    Issuance date  
Risk-free interest rate     0.49 - 0.88 %
Expected dividend yield      - %
Expected volatility     100 %
Term     5 years  
Fair value of common stock      1.95 - 2.24  

 
Schedule of company’s Options Outstanding
Warrants Outstanding   Warrants Exercisable

Exercise
Price Range

   Number
Outstanding		     Weighted Average
Remaining
Contractual Life
(in years)		     Weighted
Average
Exercise Price		     Number
Exercisable		   Weighted
Average
Exercise Price		     Intrinsic 
Value		  
$ 1.79 - $20.90     1,043,525       2.98     $ 2.57     1,043,525   $ 2.57      
-
  

 

Options Outstanding   Options Exercisable
Exercise 
Price Range		   Number Outstanding     Weighted 
Average
Remaining
Contractual Life
(in years)		     Weighted
Average
Exercise Price		     Number
Exercisable		   Weighted
Average
Exercise Price		     Intrinsic 
Value		  
$ 2.64 - $28.50     118,388       2.69     $ 3.25     118,388   $ 3.25      
-
  

 
Schedule of stock-based compensation expense
    For the years ended  
    December 31,  
    2021     2020  
Stock-based compensation expense   $ 2,687,901     $ 3,284,570  

 
Schedule of stock-based compensation expense categorized by the equity components
    For the years ended  
    December 31,  
    2021     2020  
Common stock   $ 2,687,901     $ 3,169,470  
Transfer of common stock by founders to contractors    
-
       115,100  
Total   $ 2,687,901     $ 3,284,570